A8801007 A Phase I, Healthy Volunteer Qualification Of Ligand [C 11] PF 04621053 And Randomized Determination Of H3 Receptor Occupancy Of PF 03654746, Using PET.
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2008
At a glance
- Drugs PF 3654746 (Primary)
- Indications Cognition disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 02 Dec 2008 Actual patient number (10) added as reported by ClinicalTrials.gov.
- 02 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2008 New trial record.